Route 92 Medical provides integrated neurointervention catheter platforms, such as FreeClimb and Monopoint, that use a bi‑axial telescoping design to navigate large‑bore and super‑bore catheters through tortuous cerebral vessels with minimal friction and reduced reliance on guidewires.
Funding
$50M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Neurointerventional procedures often struggle with navigating large‑bore catheters through tortuous cerebral vessels, leading to prolonged procedure times, high failure rates in reaching target lesions, and the need to combine multiple devices from different manufacturers.
Solution
Route 92 Medical offers integrated catheter platforms—FreeClimb and Monopoint—that are engineered to advance rapidly and predictably in challenging anatomy. The systems use a bi‑axial, telescoping design that nests components to reduce ledge effects and minimize friction, allowing delivery of large‑bore and super‑bore catheters with little or no guidewire assistance. By eliminating the routine use of microcatheters and reducing reliance on separate guidewire setups, the platforms shorten procedural duration and improve the likelihood of successful reperfusion. The devices are paired with compatible sheaths and delivery catheters (Tenzing 5, 7, 8) to provide consistent support from the internal carotid artery to distal M1 segments. Clinical trials such as SUMMIT MAX evaluate safety and efficacy, supporting the claim of superior performance in the most tortuous cerebrovascular pathways.
Target Audience
Primary customers are neurointerventional physicians, interventional radiologists, and stroke teams seeking faster, more reliable catheter delivery for acute ischemic stroke and other cerebrovascular interventions.
Features
- Bi‑axial, telescoping catheter architecture that nests components to reduce ledge effect and catheter‑on‑catheter friction
- Ability to deliver large‑bore (0.070") and super‑bore (0.088") catheters without a microcatheter in 100% of cases and with guidewire use in <30% of cases
- Vessel‑matched delivery catheters (Tenzing 5, 7, 8) optimized for rapid aspiration in distal vasculature and tortuous anatomy
- Integrated long sheath (Base Camp 2.0) providing enhanced support and seamless transition to ICA and beyond
- Streamlined single‑point control and tapered, atraumatic tip for atraumatic navigation through curvatures and side branches
- Designed for compatibility with a broad range of therapeutic options, removing length constraints and enabling use across multiple stroke devices